Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
Compression Garments in the Community With POTS (COM-COM-POTS)

Compression Garments are a commonly prescribed treatment in Postural Orthostatic Tachycardia Syndrome (POTS). The effectiveness of a proof-of-concept compression garment has been demonstrated in an acute laboratory setting. It is not known if commercially available compression garments that participants wear in their every day lives are effective at improving heart …

  • 0 views
  • 21 Mar, 2022
  • 1 location
Crossover Study of Propranolol vs Ivabradine in POTS

1.0 BACKGROUND Postural tachycardia syndrome (POTS) is a disorder of chronic orthostatic intolerance characterized by symptoms of palpitations, lightheadedness, chest discomfort, shortness of breath, blurred vision, and mental clouding. These symptoms occur during standing and are associated with a marked increase in heart rate (HR) in the absence of hypotension, …

  • 108 views
  • 15 Mar, 2022
  • 1 location
Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial (OCEAN)

This trial is comparing medical approaches for stroke prevention in people who have atrial fibrillation (AF) and have undergone a successful procedure called ablation to eliminate or substantially reduce the arrhythmia. AF is normally associated with an increased risk of stroke which in many patients can be prevented with appropriate …

electrocardiogram
arrhythmia
fibrillation
catheter ablation
stroke
  • 216 views
  • 07 Apr, 2022
  • 54 locations
An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients

The aim of the study is to evaluate the effectiveness and safety of the 14-day continuous ECG patch monitor (EZYPRO®) compared with a 24-hour Holter monitor in the detection of atrial

electrocardiographic monitoring
arrhythmia
fibrillation
holter monitor
  • 0 views
  • 27 May, 2022
  • 1 location
Early Diagnosis of Atrial Fibrillation in the Wait-Time Prior to Seeing a Cardiologist (CATCH-AF) (CATCH-AF)

comparison to normal ambulatory monitoring with a 24-hour Holter monitor. Patients with referrals to an Electrophysiologist, symptoms of AF but no documentation of AF, and with at least one stroke risk

dyspnea
ambulatory monitoring
arrhythmia
fibrillation
diagnostic procedure
  • 0 views
  • 23 Sep, 2022
  • 1 location
Obstructive Sleep Apnoea and Cardiac Arrhythmias (OSCA)

likely to get heart disease and abnormal heart rhythms (arrhythmias). These defects are sometimes missed by the traditional methods of monitoring i.e. 24-hour Holter monitor and ECGs. This means

continuous positive airway pressure
heart disease
holter monitor
electrocardiogram
arrhythmia
  • 43 views
  • 24 Feb, 2022
  • 1 location
Apple Watch-led Surveillance of AF Recurrence After Catheter Ablation (AFFU-AW)

(Holter monitor tests) that usually last between 1 and 7 days. However, AF recurrences can be intermittent and may not occur during these short monitoring episodes. A greater duration of monitoring has

edoxaban
electrocardiogram
arrhythmia
warfarin
catheter ablation
  • 0 views
  • 04 Oct, 2022
  • 1 location
Low Workload Concept for the Detection of Silent Atrial Fibrillation (AF) and Atrial Fibrillation Burden in Patients at High Risk of AF and Stroke (CARE-DETECT)

Patient-centered novel e-health technology and services will lay the foundation for future healthcare systems and services to support health and welfare promotion. Yet, there is a lack of ways to incorporate novel technological innovations into easy-to-use, cost-effective and low workload treatment. The detection of atrial fibrillation (AF) paroxysms and its …

arrhythmia
fibrillation
bypass graft
stroke
heart surgery
  • 0 views
  • 29 Jun, 2022
  • 1 location
BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS

To assess the efficacy, and safety of BST-236 in patients unfit for intensive chemotherapy with AML or HR MDS that failed or relapsed following first line therapy

ejection fraction
cytarabine
decitabine
carbon monoxide
acute leukemia
  • 0 views
  • 04 Oct, 2022
  • 7 locations
ASsessment Of RiLuzole To Reduce Paroxysmal Episodes of Atrial FIbrillatiON (The SOLUTION Study) (SOLUTION)

Atrial fibrillation (AF) is a growing clinical problem.1 AF is a highly dynamic condition involving episodes of sinus rhythm interspersed with periods of arrhythmia, becoming more difficult to terminate over time. AF carries a substantial cost, morbidity and mortality burden. There are two important approaches to the management of AF: …

  • 0 views
  • 19 Sep, 2022
  • 1 location